Latest filing published 05 Mar 2026 for Elanco Animal Health Inc, €73k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
All filings by David S. Kinard on record concern Elanco Animal Health Inc, in the capacity of chief executive. The record holds 12 filings, for trades running from 20 October 2021 to 3 March 2026.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
On 5 March 2026 came the latest disclosure, a share grant for €73k in Elanco Animal Health Inc. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
12 of 12 declarations